Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on MorphoSys AG. We currently have 18 research reports from 3 professional analysts.
Date | Source | Announcement |
---|---|---|
24Apr24 15:40 | EQS-News | EQS-News: MorphoSys präsentiert neue Daten der Phase 3 MANIFEST-2 Studie zu Pelabresib bei Myelofibrose in mündlichem Vortrag auf der ASCO-Jahrestagung 2024 |
24Apr24 15:40 | EQS-News | EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting |
24Apr24 15:00 | DGAP-AHD | EQS-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
24Apr24 15:00 | DGAP-AHD | EQS-PVR: MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung |
23Apr24 15:02 | DGAP-AHD | EQS-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
23Apr24 15:02 | DGAP-AHD | EQS-PVR: MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung |
23Apr24 15:01 | DGAP-AHD | EQS-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
Share: